Psychiatric Times
CONTINUE TO SITE

OR WAIT null SECS

Psychiatric Times
Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
Topics
Media
Publications
Job BoardCME/CEPartners
Resources
Subscribe

  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.

SpotlightSee All >
  • Bipolar I Disorder
  • Psychedelics
  • (Sponsored) Taar1 Agonism: A Novel Approach to Treating Schizophrenia
  • Between the Lines: Narcolepsy
  • Case Reviews in Bipolar Disorder: Around The Practice
  • Major Depressive Disorder
  • Managing Patients With Treatment Resistant Depression
  • Perspectives in Insomnia
  • Sleep Disorders
CommentarySee All >
  • Couch In Crisis
  • Early Career Psychiatry
  • History of Psychiatry
  • Residents Corner
Cultural CornerSee All >
  • Film and Book Reviews
  • Poetry
  • Writers Contest
Psychiatric PracticeSee All >
  • Burnout
  • Careers
  • Coding
  • Guidelines
  • Risk Management
  • Telepsychiatry
SeriesSee All >
  • Climate Change
  • Critical Conversations in Psychiatry
  • Portraits
  • Psychiatric Views on the Daily News
  • Tales From the Clinic: The Art of Psychiatry
  • Tales from the New Asylum
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.

EP 1: Case 2: Starting a Patient on Intranasal Esketamine

October 21st 2021

Lisa Harding, MD, and Angelos Halaris, MD, PhD, APA, ACNP, CINP, discuss their thoughts on starting treatment with intransal esketamine and what to expect.